AF
AVIR icon

Allworth Financial’s Atea Pharmaceuticals AVIR Stock Holding History

Allworth Financial’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$958 Buy
+178
New +$817 ﹤0.01% 4585
2025
Q4 		– Sell
-63
Closed -$183 – 5031
2025
Q3 		$183 Buy
+63
New +$215 ﹤0.01% 4616

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Allworth Financial's AVIR Position: Q1 2026 in Review

Allworth Financial opened a new position in Atea Pharmaceuticals (AVIR) in Q1 2026: 178 shares worth $958. The stake represents ﹤0.01% of the portfolio and ranks #4585 among its holdings. This is a return to the name: Allworth Financial previously reported a position in AVIR as recently as Q3 2025.

Allworth Financial first reported a position in AVIR in Q3 2025 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Allworth Financial held 178 shares of Atea Pharmaceuticals worth $958 as of Q1 2026.
  • Atea Pharmaceuticals was a new Allworth Financial position in Q1 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4585 holding.
  • Allworth Financial first reported a position in Atea Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.